Intravesical Instillations of 4-EPI-Doxorubicin (Epirubicin) in the Prophylactic Treatment of Superficial Bladder Cancer: Results of a Controlled Prospective Study (Q67734004)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 1992

Language	Label	Description	Also known as
English	Intravesical Instillations of 4-EPI-Doxorubicin (Epirubicin) in the Prophylactic Treatment of Superficial Bladder Cancer: Results of a Controlled Prospective Study	scientific article published on 01 February 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactic treatment of superficial bladder cancer: results of a controlled prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Intravesical Instillations of 4-EPI-Doxorubicin (Epirubicin) in the Prophylactic Treatment of Superficial Bladder Cancer: Results of a Controlled Prospective Study (English)

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

0 references

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

author name string

M. D. Melekos

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732596

11 November 2022

H. Dauaher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732596

11 November 2022

E. Fokaefs

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732596

11 November 2022

G. Barbalias

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1732596

11 November 2022

language of work or name

0 references

publication date

1 February 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:S0022534717372403?httpAccept=text/xml

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

https://api.elsevier.com/content/article/PII:S0022534717372403?httpAccept=text/plain

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2937240-3

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

371-375

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Benign Papilloma or Papillary Carcinoma of the Bladder?

1

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

2

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data

5

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

The relative survival rate: a statistical methodology

11

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Maximum utilization of the life table method in analyzing survival

12

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group

14

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Superficial bladder cancer: progression and recurrence

15

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resectio

17

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

The treated histories of patients with Ta grade 1 transitional-cell carcinoma of the bladder

18

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

19

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Multicenter study of superficial bladder cancer treated with intravesical bacillus Calmette-Guérin or adriamycin

20

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients

21

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer

22

1 reference

10.1016/S0022-5347(17)37240-3

https://api.crossref.org/works/10.1016/S0022-5347(17)37240-3

11 November 2022

Identifiers

10.1016/S0022-5347(17)37240-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1732596%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67734004&oldid=1814501962"